SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Canaccord Genuity Initiates Tonix Coverage With Buy Rating, $18 Target

Canaccord Genuity initiated coverage of Tonix Pharmaceuticals with a Buy rating and an $18 price target.

TNXP

Related stories